27 July 2022 : Meta-Analysis
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
Mengjie Li1234ABCDEFG, Guangzhi Ma1ABCDEF, Xuebing Li2ACFG*, Qinghua Zhou12ACFGDOI: 10.12659/MSM.936898
Med Sci Monit 2022; 28:e936898
Figure 3 Forest plots of overall outcomes for progression-free survival (PFS). Hazard ratios (HRs) for each trial are represented by the squares, and the horizontal lines crossing the square show the 95% confidence intervals (CIs). The diamonds represent the estimated pooled effect of the overall outcome for PFS in NSCLC. All P values are two-sided. STATA (version 13.1; Stata Corporation, College Station, TX, USA) was used.